Učitavanje...
Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease
Background/Aims: Dapagliflozin (DAPA) is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) which induces glucosuria and osmotic diuresis. The therapeutic effect of DAPA in progressing stages of polycystic kidney disease (PKD) has not been studied. Methods: We examined the effect of...
Spremljeno u:
Glavni autori: | , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Karger Publishers
2015-12-01
|
Serija: | Kidney & Blood Pressure Research |
Teme: | |
Online pristup: | http://www.karger.com/Article/FullText/368540 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|